Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
The $100 Billion Court Challenge for Goldman and Friends
Marc Rubinstein is a former hedge fund manager. He is author of the weekly finance newsletter Net Interest.
The Australian Financial Review5d
Goldman Sachs’ small caps analyst exits the bank
Wall Street investment bank Goldman Sachs is a man down in its small-cap equity research team. Street Talk understands analyst Chris Gawler left the building in the weeks after Goldman posted its ...
Business Insider10d
Goldman Sachs
"In our view this is a correction and not the start of a sustained bear market," Goldman Sachs said. DeepSeek sparked a $1 trillion market rout on Monday. Inside the careers, accomplishments ...